D-0186-2025 Class II Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0186-2025 was initiated by Eugia US LLC on Dec 27, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial. The recall status is ongoing. Affected quantity: 17,300 10-mL vials.

Recall details

Product Type
Drugs
Report Date
Jan 15, 2025
Initiation Date
Dec 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,300 10-mL vials

Product description

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Reason for recall

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Distribution pattern

Distributed Nationwide in the USA.

Code information

Batch # 1PR24010, Expiry: 02/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0186-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0186-2025. Report a data issue: hello@regdatalab.com.